DAFNA Capital Management LLC
Position in SNDX — Syndax Pharmaceuticals Inc
CIK 1389933
LOS ANGELES, CA
Position in SNDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,328,674
+$2,251,262 QoQ
Shares Held
335,255
+54.2% QoQ
Ownership
0.375%
of shares outstanding
% of Portfolio
1.49%
of 13F equity value
Holder Rank
#59
of 242 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DAFNA Capital Management LLC holds $345,637,467 across 65 Biotechnology names. SNDX ranks #11 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
562,630 | $105,369,346 | |
| 2 | NKTR |
Nektar Therapeutics
|
318,380 | $22,226,107 | |
| 3 | DNLI |
Denali Therapeutics Inc.
|
739,014 | $19,007,440 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
497,240 | $18,532,134 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
250,772 | $15,136,597 | |
| 6 | CYTK |
Cytokinetics Inc
|
171,998 | $14,652,509 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
441,829 | $13,621,588 | |
| 8 | ASND |
Ascendis Pharma A/S
|
48,469 | $12,927,651 |
All Filings in SNDX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,328,674 | 335,255 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,077,412 | 217,355 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,837,733 | 277,855 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,703,300 | 500,702 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,090,832 | 543,602 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,689,207 | 544,502 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,165,266 | 542,002 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,139,013 | 526,702 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,489,729 | 657,074 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $15,697,861 | 659,574 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $16,047,024 | 742,574 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,655,575 | 458,373 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,436,771 | 450,873 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,442,181 | 447,073 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $11,378,007 | 447,073 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,542,352 | 355,487 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,137,789 | 370,987 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,465,134 | 371,987 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,491,151 | 296,535 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,542,215 | 80,702 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,536,043 | 147,702 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,285,700 | 57,500 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $222,400 | 10,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,516,043 | 102,713 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $5,335,200 | 360,000 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||